(Q74617283)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10083541%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Simulect (basiliximab) reduces acute cellular rejection in renal allografts from cadaveric and living donors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10083541%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

L L Mulloy

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10083541%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

F Wright

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10083541%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

M L Hall

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10083541%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

M Moore

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10083541%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

language of work or name

English

0 references

publication date

1 February 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10083541%20AND%20SRC:MED&resulttype=core&format=json

Transplantation Proceedings

12 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10083541%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10083541%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10083541%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

1210-1213

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10083541%20AND%20SRC:MED&resulttype=core&format=json

Prolonged action of a chimeric interleukin-2 receptor (CD25) monoclonal antibody used in cadaveric renal transplantation

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902094-6

7 January 2021

Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902094-6

7 January 2021

The incidence and impact of early rejection episodes on graft outcome in recipients of first cadaver kidney transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902094-6

7 January 2021

Early versus late acute renal allograft rejection: impact on chronic rejection.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902094-6

7 January 2021

The impact of an acute rejection episode on long-term renal allograft survival (t1/2)

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2902094-6

7 January 2021

10.1016/S0041-1345(98)02094-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10083541%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference